|
ZNF398 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.475600E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.359900E-03 |
| Normal-vs-Stage2 |
1.715600E-01 |
| Normal-vs-Stage3 |
3.543100E-03 |
| Normal-vs-Stage4 |
3.743600E-02 |
| Stage1-vs-Stage2 |
8.400600E-01 |
| Stage1-vs-Stage3 |
4.044800E-01 |
| Stage1-vs-Stage4 |
4.774600E-01 |
| Stage2-vs-Stage3 |
3.856400E-01 |
| Stage2-vs-Stage4 |
4.162200E-01 |
| Stage3-vs-Stage4 |
8.439400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.159740E-03 |
| Normal-vs-AfricanAmerican |
9.351700E-02 |
| Normal-vs-Asian |
1.831970E-01 |
| Caucasian-vs-AfricanAmerican |
4.257000E-01 |
| Caucasian-vs-Asian |
8.766000E-01 |
| AfricanAmerican-vs-Asian |
8.977200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.595190E-04 |
| Normal-vs-Female |
8.891800E-01 |
| Male-vs-Female |
1.408240E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.324200E-03 |
| Normal-vs-Extreme_Weight |
2.281200E-03 |
| Normal-vs-Obese |
8.994100E-02 |
| Normal-vs-Extreme_Obese |
3.560700E-04 |
| Normal_Weight-vs-Extreme_Weight |
8.676800E-01 |
| Normal_Weight-vs-Obese |
1.619160E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.764200E-01 |
| Extreme_Weight-vs-Obese |
2.002800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.843400E-01 |
| Obese-vs-Extreme_Obese |
7.776400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.473000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.868390E-01 |
| Normal-vs-Age(61-80Yrs) |
1.004520E-04 |
| Normal-vs-Age(81-100Yrs) |
1.511810E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.062400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.332600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.121000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.453850E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.892000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.130200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.736300E-02 |
| Normal-VS-Type2 PRCC |
2.00459999710745E-08 |
| Normal-VS-KIRP CIMP |
3.904700E-03 |
| Normal-VS-Unclassified PRCC |
3.495000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.55419999999795E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.529000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.852400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.791000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.066100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.143800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.39160000001137E-06 |
| Normal-vs-N1 |
7.114300E-02 |
| Normal-vs-N2 |
1.779900E-02 |
| N0-vs-N1 |
1.403000E-01 |
| N0-vs-N2 |
9.072600E-01 |
| N1-vs-N2 |
5.998600E-01 |
|
|
